HemaSphere Journal Citation Rate 2026
2572-9241
Wolters Kluwer
US
Q2 Quartile Open Access Established Impact
About HemaSphere
HemaSphere (H) is a peer-reviewed academic journal covering Acute Myeloid Leukemia Research and Chronic Lymphocytic Leukemia Research, published by Wolters Kluwer in US, catalogued under ISSN 2572-9241. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.66 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $1200 USD. OpenAlex records 9,409 works and 19,008 citations, with an h-index of 52.
HemaSphere Citation Rate 2026 — In Context
HemaSphere has a 2025 2-Year Citation Rate (OpenAlex) of 2.66, placing it in the Q2 quartile within the Acute Myeloid Leukemia Research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, HemaSphere makes all articles freely available to readers for an Article Processing Charge of approximately $1200 USD.
Researchers looking to publish in HemaSphere should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare HemaSphere against similar journals in the field, use our journal comparison tool.
Submission Tips for HemaSphere
- Budget $1200 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How HemaSphere Compares
Compared against 21 journals in the same research areas.
| ISSN (Print) | 2572-9241 |
|---|---|
| Publisher | Wolters Kluwer |
| Country | United States |
| APC / Cost | $1200 USD |
In-depth profile & metrics
HemaSphere is published by Wolters Kluwer and based in United States. It publishes open access with an article-processing charge of USD 1200.
In our subject taxonomy, HemaSphere is classified under Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Multiple Myeloma Research and Treatments.
HemaSphere is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 2.656.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about HemaSphere
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 2.656 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare HemaSphere against similar publications in its field:
Related Journals in Your Field
-
Modern Pathology Elsevier BV IF 5.84
-
Leukemia Springer Nature IF 5.73
-
American Journal of Hematology Wiley IF 4.50
-
Blood Advances Elsevier BV IF 4.44
-
Bone Marrow Transplantation Springer Nature IF 2.73
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S4210211592
Get weekly updates for Acute Myeloid Leukemia Research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.